4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-058172
President and CEO sold 43,485 shares at an average $18.02 ($783,574)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2019-11-22 | Sale | −1,300 | $18.00 | $23,400 | 2,492,757 | I |
| Watts Ryan J. President and CEO | 2019-11-25 | Sale | −42,185 | $18.02 | $760,174 | 2,450,572 | I |
| Open-market sales · 43,485 sh · avg $18.02 · $783,574 | |||||||
Loading xslF345X03/doc4.xml…